Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System
|
|
- Dominick Townsend
- 6 years ago
- Views:
Transcription
1 Cancer Research UK Clinical Trials/Research Unit Glasgow Quality System BEATSON WEST OF SCOTLAND CANCER CENTRE POLICY ON THE AWARENESS AND TRAINING OF STAFF MANAGING PATIENTS WITHIN THE CONTEXT OF A CLINICAL TRIAL To: All staff involved in managing patients on clinical trials within NHS Greater Glasgow and Clyde Health Board From: Clinical Trials Executive Committee Date: 08 Oct INTRODUCTION This policy document describes the levels of awareness or training in Good Clinical Practice (GCP) required for staff who manage patients on clinical trials conducted within NHS Greater Glasgow and Clyde Health Board (NHSGG&C) which have been approved by the Beatson West of Scotland Cancer Centre s Clinical Trials Executive Committee, based on their levels of involvement with trial patients. It also describes the level of training in the individual trial protocol that is required by these staff. 2. BACKGROUND All staff who manage patients in clinical trials must understand what awareness and/or training they require to carry out their role. There are two specific areas of awareness and training; the principles of GCP and the specific protocol(s) for the trial(s) on which they are working. The levels of awareness or training in each of these domains will depend upon the nature of the activities that they are delegated to perform. These levels are targeted at all individuals who may perform activities within clinical trials, e.g. radiographers, pharmacy staff, auxiliary staff, doctors, nurses. 3. LEVELS OF TRIAL INVOLVEMENT There are 3 levels of involvement for staff that manage trial patients within the BWoSCC: Level 1: Activity that is specified in the trial protocol, but which is conducted in exactly the same way as in routine care, e.g. recording of BP or ECG, and is conducted by an individual who would normally perform these activities during routine care. Level 2: Activity that is specified within the trial protocol and is unique to the trial, but which is within the normal remit of clinical responsibility for that member of staff. For example: o The administration of IV Investigational Medicinal Product (IMP) by a nurse trained in the administration of IV drugs. o Following an approved local dispensing procedure by pharmacy staff. In practice, there are few other examples. Level 3: Activity that is trial-specific and does not fall within the normal remit of clinical responsibility for the individual. Many activities performed by sub-investigators, research nurses and lead pharmacy contacts will fall into this category. Appendix II contains a list of examples of duties that would be performed at the above levels. 4. LEVELS OF AWARENESS/TRAINING Page 1 of 5 Version 2: 08 Oct 2015
2 For each activity level, there are corresponding degrees of training required in GCP and also trial-specific training: Level 1: 1. GCP training a brief GCP awareness document will be available to these staff members to consult in their area of activity, but no record will be kept as to whether or not this document has been received by individuals. 2. Trial-specific training no trial specific training is required, and these staff will not be listed on trial delegation logs or training logs. The responsibility for protocol compliance will lie with the member of the trial team who is instructing the individual to carry out this activity. The fact that the individual carrying out the activity does so as part of clinical job is considered sufficient evidence of training in the activity. The individual is not delegated to perform any activity within the trial that is not part of their everyday practice. Level 2: 1. GCP training abbreviated training will be provided to all relevant staff prior to undertaking trial activity. For Example: For nurses administering IV IMPs, this training will be part of the Chemotherapy Course, which is mandatory for all such staff. For other staff groups this will be organised by the appropriate line managers. This training will be documented and traceable, but will not necessarily be subject to planned or documented review unless there are significant changes in training requirements. 2. Trial-specific training this will depend on the staff group. For example: Nursing staff in this category will be made aware that the patient is on a clinical trial and will be informed as to whom to contact regarding that trial in the event of any concerns/aes. The mode of this communication will be dependent on the activity, e.g. for IMP administration this information will be on the chemotherapy prescription. Pharmacy staff in this category will undertake trial-specific training in relation to the locally approved dispensing procedures. This training will be carried out by a member of the lead pharmacy contacts team or another member of the pharmacy team, using a cascade system. This training will be documented on a training log that is stored in the pharmacy site file for the project. Level 2-only staff will not be required to sign a delegation log, but their signature next to the activity (e.g. on the chemotherapy prescription) will constitute such signature and will be filed in the source documentation but not the Investigator Site File (ISF). Level 3: 1. GCP training full GCP training must be undertaken by this group. This will be certificated, traceable and subject to renewal in accordance with an agreed renewal schedule (currently every 2 years). Please refer to the NHS Greater Glasgow and Clyde policy on GCP. 2. Trial-specific training The Principal Investigator (PI) is ultimately responsible for the training of this group in all delegated activities within the trial. Trial-specific training logs should be maintained in the ISF and all individuals undertaking these activities will be delegated to do so by the PI and this will be recorded in the delegation log in the ISF. 3. Any member of staff who prescribes IMPs must undergo full GCP training and be listed on delegation logs. There may be some exceptions to the activities which would typically be carried out under Level 3 training, whereby certain activities may be carried out by staff who have Level 2 training only, for example, non-medical prescribing. However, this practice will only be permitted on a case by case basis, following a risk assessment by the trial Sponsor and subsequent agreement between the R&D Governance Department and the trial Sponsor. 5. CTEC REVIEW and RISK ASSESSEMENT When a trial is reviewed by CTEC, the committee will identify the level of research resource to be provided for each trial. In some circumstances (e.g. clinical trials operating within the Clinical Research Unit), all trial activity will be conducted by individuals who are fully training in the protocol and GCP (e.g. Research nurses, doctors and lead pharmacy contacts). In such cases, it may be irrelevant what levels of activity are to be undertaken. When this is not the case, the CTEC Chair will conduct a risk assessment to identify any duties that fall within Level 2 (as documented in Section 3, above). Page 2 of 5 Version 2: 08 Oct 2015
3 6. RETENTION OF THE POLICY DOCUMENT This policy is accessed via the public area of the CRUK CTU website. Document control, distribution and retention are managed by the CRUK CTU Quality Assurance Manager, who is responsible for ensuring that the correct version is always available, the document is reviewed appropriately and timeously, and that superseded versions are archived appropriately. 7. REFERENCES NHS Greater Glasgow and Clyde Good Clinical Practice Policy 8. DOCUMENT HISTORY Version Approved Effective Reviewed Comments Version 1 11 Jan Jan Jul 2015 Additions to text in Sections 1 and 4. Addition of Section 6 Retention of the document. Version 2 Version 3 (Revision author: Michaela Rodger) Page 3 of 5 Version 2: 08 Oct 2015
4 Appendix I How do I know my patient is in a clinical study? The patient s case records will have a white sticker CLINICAL TRIAL PATIENT Please check inside notes for any instructions pertaining to the study CTU Contact for Study: CTC: Ext: Study No: Why do I need to know? For patient safety The Research Team for each study is responsible for the conduct of the study in this hospital. This includes reporting patient events which may be linked to their study participation to regulatory authorities. Please note All clinicians must report any Serious Adverse Events to the CTU immediately and fully document the event in case notes The Patient Information Sheet (PIS) and consent form will be filed in the case records along with the orange registration/randomisation sheet The Chemocare prescription identifies o the Beatson Study Number o which treatments are Investigational Medicinal Product (IMP) o the Research Team contact details What do I need to report? The Research Team need to know Any hospital admissions Any change to the patient treatment schedule Any abnormal observation parameters Any treatment compliance concerns Document in the case records and contact the Research Team Who should I ask? Every study has a Principal Investigator and a Clinical Trial Coordinator. Where possible there is also a Research Nurse assigned to the study. A general query? Contact the Clinical Trial Coordinator (CTC) A treatment related query? Contact the treatment prescribing medic or clinical trial pharmacist A concern about the study? The Principal Investigator, the local clinician responsible for the study Page 4 of 5 Version 2: 08 Oct 2015
5 Appendix II Examples of duties categorised as levels 1, 2 and 3 Level Duties Staff Group 1 Blood pressure Nursing 1 Pulse Nursing 1 Temperature Nursing 1 Respirations Nursing 1 Pulse Oximetry Nursing 1 Height Nursing 1 Weight Nursing 1 Urinalysis Nursing 1 Urine pregnancy test Nursing 1 ECG recording Nursing 1 Blood glucometer recording Nursing 1 Phlebotomy Nursing 1 Cannulation Nursing 1 Administration of IV drugs which are non IMP (NIMP) Nursing 1 Administration of IV chemotherapy which are NIMP Nursing 1 Administration of subcutaneous and intramuscular drugs which are NIMP Nursing 1 Administration or oral drugs which are NIMP Nursing 1 Administration of oral chemotherapy which are NIMP Nursing 2 Administration of trial drugs which are IMP Nursing 2 Receipt of IMP Pharmacy 2 Environmental Temperature Monitoring Pharmacy 2 Dispensing of NIMP Pharmacy 2 Dispensing of IMP for Phase II-IV trials Pharmacy 2 Accountability of IMP Pharmacy 2 Reconciliation of IMP Pharmacy 2 Destruction of IMP with sponsor approval Pharmacy 3 Any trial activity not covered by levels 1 and 2 Page 5 of 5 Version 2: 08 Oct 2015
ACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationSetting up a Clinical Trial
York Foundation Trust R&D Unit SOP Pharm/S45 Setting up a Clinical Trial IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING USED All staff should regularly check
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationSTH Researcher. Recording of research information in patient case notes
STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationSOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationDocument Title: Study Data SOP (CRFs and Source Data)
Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationUHS Clinical Trials Assistant Development Programme:
UHS Clinical Trials Assistant Development Programme: Developing the research workforce and introducing new healthcare roles to support research nurses. Marie Nelson Matron Research and Development & Emma
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationSite Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG
Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG INFORMATION AND GUIDANCE SHEET FOR THE COMPLETION OF THE SITE SIGNATURE AND
More informationSOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection
SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationGCP INSPECTION CHECKLIST
(This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationA Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off
Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: 2012-004260-22 REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationQUALITY ASSURANCE PROGRAM
QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support
More informationTRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
More informationChecklist prior to recruiting first patient
Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient
More informationMarie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:
More informationJOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.
JOB DESCRIPTION JOB TITLE: Pharmacy Technician Haematology Clinical Trials PAY BAND: Agenda for change - Band 5 TERMS AND CONDITIONS DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PROFESSIONALLY RESPONSIBLE
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationSTANDARD OPERATING PROCEDURE SOP 205
STANDARD OPERATING PROCEDURE SOP 205 Adverse Events: Identifying, Recording and Reporting for CTIMPs Sponsored by the Norfolk and Norwich University Hospital NHS Foundation Trust Version 2.3 Version date
More informationJoint R&D Support Office SOP S-2011 UHL
UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for
More informationResearch & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff
Department Title of SOP Research & Development Case Report Form SOP SOP reference no: R&D GCP SOP 03 Authors: Current version number and date: J H Pacynko and J Illingworth Version 2, 01.02.18 Next review
More informationSYSTEMS 2 (L160) A Randomised Phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma
SYSTEMS 2 (L160) A Randomised Phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma ISRCTN No: ISRCTN12698107 Protocol No: SYSTEMS 22015
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationGovernance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationClinical Study Risk Assessment
Clinical Study Risk Assessment Clinical S.O.P. No.: 19 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited number by 1.0 New SOP Shona
More informationI2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator
I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationSTANDARD OPERATING PROCEDURE SOP 345. Identifying Trial Patients on Hospital Admission
STANDARD OPERATING PROCEDURE SOP 345 Identifying Trial Patients on Hospital Admission Version 1.3 Version date 22/02/2018 Effective date 24/02/2018 Number of pages 6 Review date January 2020 Author Role
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationThis Agreement dated DD/MM/YYYY (the Effective Date ) is between
Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7
More informationPrescribing Lactoferrin in the ELFIN Clinical trial
Prescribing Lactoferrin in the ELFIN Clinical trial PAULA JENKINS RESEARCH NURSE NPEU Why Lactoferrin is deemed an Investigational Medicinal Product any substance or combination of substances presented
More informationCOMPETENCY FRAMEWORK
COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationCLINICAL TRIALS ASSISTANT - BEATSON CLINICAL TRIALS UNIT Boc Trials Unit Beatson West of Scotland Cancer Centre
CLINICAL TRIALS ASSISTANT - BEATSON CLINICAL TRIALS UNIT Boc Trials Unit Beatson West of Scotland Cancer Centre Job Reference: 0000051660G Closing Date: 25 May 2018 Dear applicant, Thank you for your interest
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationSFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check
Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Overview This standard describes the skills, knowledge and understanding required to demonstrate competence
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationAdverse Event Reporting
Adverse Event Reporting Clinical S.O.P. No.: 15 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited Date edited number by 1.0 New SOP
More informationPolicy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition)
Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition) Document Summary This Policy defines the clinical procedures for all Clinical staff (including temporary staff, contracted
More informationDESTRUCTION AND RETENTION OF CLINICAL HEALTH RECORDS POLICY
Directorate of Operations Central Operations Group Corporate Library Services DESTRUCTION AND RETENTION OF CLINICAL HEALTH RECORDS POLICY Reference: OPP023 Version: 1.7 This version issued: 02/05/12 Result
More informationR. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective
More informationPrescribing and Administration of Medication Procedure
Prescribing and Administration of Medication Procedure Version: 3.3 Bodies consulted: - Approved by: PASC Date Approved: 1.4.16 Lead Manager Lead Director: Head of Child and Adolescent psychiatry Medical
More informationRecommendations for the Retention of Pharmacy Records - prepared by the East of England NHS Senior Pharmacy Managers
Recommendations for the Retention of Pharmacy s - prepared by the East of England NHS Senior Pharmacy Managers 2012-13 RECORDS THAT PERTAIN TO ALL PHARMACY SETTINGS Clinical governance Competency/training
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationAssessment criteria The learner can:
HSC 3052: Undertake measurements Unit reference R/601/8662 Level 3 Credit value 3 GLH 23 Unit aim This unit is aimed at health & social care staff involved in the taking and ing of measurements as part
More informationCLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre
CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre Job Reference: 0000046503G Closing Date: 7 th April 2017 Dear applicant, Thank you for your interest in this post
More informationEffective Date: 11/09 Policy Chronicle:
Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:
More informationMINNESOTA. Downloaded January 2011
MINNESOTA Downloaded January 2011 4658.1300 MEDICATIONS AND PHARMACY SERVICES; DEFINITIONS. Subpart 1. Controlled substances. "Controlled substances" has the meaning given in Minnesota Statutes, section
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationColorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements
6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services
More informationManagement of Reported Medication Errors Policy
Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationGuidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities. July 2011
Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities July 2011 Introduction: This guidance sets out strengthened governance arrangements required
More informationGuidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by
Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by Contract Research Organisations (CRO mcia, 2011 version)
More informationOffice of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators
Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationSTANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office
STANDARD OPERATING PROCEDURE SOP 220 Investigation of allegations of Research Fraud and Misconduct Version 1.4 Version date 27.02.2018 Effective date 2.03.2018 Number of pages 8 Review date February 2020
More informationIDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES
IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October
More informationNN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION
NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationStandard Operating Procedures
Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More informationClinical Trial Readiness Checklist October 2014
The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the
More informationStudy Monitoring Plan Template
Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More information